相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Memantine nanoemulsion: a new approach to treat Alzheimer's disease
Atinderpal Kaur et al.
JOURNAL OF MICROENCAPSULATION (2020)
Procognitive profiling of a serotonin 5-HT6 receptor antagonist in a complex model system in rats: A novel translational approach for clinical prediction
Istvan Gyertyan et al.
BRAIN RESEARCH BULLETIN (2020)
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Aleksandra Zielinska et al.
MOLECULES (2020)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nanotechnology approaches for enhanced CNS delivery in treating Alzheimer's disease
M. A. Arya et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects
Pascale Barbier et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia
Rosalinde E. R. Slot et al.
ALZHEIMERS & DEMENTIA (2019)
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease
Lin Jia et al.
MOLECULAR BRAIN (2019)
Choroid plexus tumor necrosis factor receptor 1: a new neuroinflammatory piece of the complex Alzheimer's disease puzzle
Sophie Steeland et al.
NEURAL REGENERATION RESEARCH (2019)
2019 Alzheimer's disease facts and figures
Joseph Gaugler et al.
ALZHEIMERS & DEMENTIA (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases
Z-M Wang et al.
PHARMACOGENOMICS JOURNAL (2018)
The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease
Ji Cheng et al.
AGING CELL (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Molecular properties underlying regional vulnerability to Alzheimer's disease pathology
Michel J. Grothe et al.
BRAIN (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
Spreading of Tau Pathology in Sporadic Alzheimer's Disease Along Cortico-cortical Top-Down Connections
Heiko Braak et al.
CEREBRAL CORTEX (2018)
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2018)
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
Dario Carradori et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Tau Activates Transposable Elements in Alzheimer's Disease
Caiwei Guo et al.
CELL REPORTS (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
Oxidative stress and the amyloid beta peptide in Alzheimer's disease
C. Cheignon et al.
REDOX BIOLOGY (2018)
Deficient Wnt Signaling and Synaptic Vulnerability in Alzheimer's Disease: Emerging Roles for the LRP6 Receptor
Johanna Buechler et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2018)
Structural Mechanisms of Gating in Ionotropic Glutamate Receptors
Edward C. Twomey et al.
BIOCHEMISTRY (2018)
Donepezil for dementia due to Alzheimer's disease
Jacqueline S. Birks et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Alzheimer's disease: experimental models and reality
Eleanor Drummond et al.
ACTA NEUROPATHOLOGICA (2017)
Lentiviral Modulation of Wnt/β-Catenin Signaling Affects In Vivo LTP
Olga Ya Ivanova et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges
Ming Ming Wen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Alzheimer's Disease: Past, Present, and Future
Mark W. Bondi et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)
Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
Sergey O. Bachurin et al.
MEDICINAL RESEARCH REVIEWS (2017)
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
Wei Qiang et al.
NATURE (2017)
Cryo-EM structures of tau filaments from Alzheimer's disease
Anthony W. P. Fitzpatrick et al.
NATURE (2017)
On the path to 2025: understanding the Alzheimer's disease continuum
Paul S. Aisen et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Alexandre Bejanin et al.
BRAIN (2017)
PAMAM dendrimers in drug delivery: loading efficacy and polymer morphology
P. Chanphai et al.
CANADIAN JOURNAL OF CHEMISTRY (2017)
Resveratrol for Alzheimer's disease
Christine Sawda et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Molecular Pathogenesis of Alzheimer's Disease: An Update
Alfredo Sanabria-Castro et al.
ANNALS OF NEUROSCIENCES (2017)
Molecular genetics of early-onset Alzheimer's disease revisited
Rita Cacace et al.
ALZHEIMERS & DEMENTIA (2016)
Alzheimer's Disease: Targeting the Cholinergic System
Talita H. Ferreira-Vieira et al.
CURRENT NEUROPHARMACOLOGY (2016)
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease
Lidia Bakota et al.
DRUGS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
Qing-Fei Zhao et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Frizzled-1 receptor regulates adult hippocampal neurogenesis
Muriel D. Mardones et al.
MOLECULAR BRAIN (2016)
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
Jaume Folch et al.
NEURAL PLASTICITY (2016)
Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau
Di Xia et al.
SCIENTIFIC REPORTS (2016)
The blood-brain barrier and nasal drug delivery to the central nervous system
Marcel Menon Miyake et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2015)
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Jason M. Lajoie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Establishment and Dysfunction of the Blood-Brain Barrier
Zhen Zhao et al.
CELL (2015)
SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging
Lucas A. Lane et al.
CHEMICAL REVIEWS (2015)
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Michael Willem et al.
NATURE (2015)
Tau stabilizes microtubules by binding at the interface between tubulin heterodimers
Harindranath Kadavath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer's Disease
Mohammad Z. Ahmad et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Insights into direct nose to brain delivery: current status and future perspective
Deepti Mittal et al.
DRUG DELIVERY (2014)
Quantitative analysis of drug delivery to the brain via nasal route
Luba Kozlovskaya et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Intranasal therapeutic strategies for management of Alzheimer's disease
Sumeet Sood et al.
JOURNAL OF DRUG TARGETING (2014)
Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease
Bellinda Benhamu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors
Sandra I. Mota et al.
NEUROPHARMACOLOGY (2014)
cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex
Becky C. Carlyle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Polymeric nano-micelles: versatile platform for targeted delivery in cancer
Salma Mohamed et al.
THERAPEUTIC DELIVERY (2014)
CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis
Kyoung-Jin Oh et al.
BMB REPORTS (2013)
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
Daniela Puzzo et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Inhibition of GSK3 beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Philip T. T. Ly et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Synaptic Protein alpha 1-Takusan Mitigates Amyloid-beta-Induced Synaptic Loss via Interaction with Tau and Postsynaptic Density-95 at Postsynaptic Sites
Nobuki Nakanishi et al.
JOURNAL OF NEUROSCIENCE (2013)
Overcoming barriers and thresholds - signaling of oligomeric Aβ through the prion protein to Fyn
Hansen Wang et al.
MOLECULAR NEURODEGENERATION (2013)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
LRP5 and LRP6 in development and disease
Danese M. Joiner et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
5-HT6 receptors and Alzheimer's disease
Maria Javier Ramirez
ALZHEIMERS RESEARCH & THERAPY (2013)
Targeted Blood-to-Brain Drug Delivery – 10 Key Development Criteria
Pieter J. Gaillard et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Improvement of drug safety by the use of lipid-based nanocarriers
Sok Bee Lim et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens
Ricarda Cortes-Vieyra et al.
JOURNAL OF INFLAMMATION-LONDON (2012)
ASPECTS REGARDING THE NEUROBIOLOGY OF PSYCHO-AFFECTIVE FUNCTIONS
Alin Ciobica et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2012)
Nanoemulsions versus microemulsions: terminology, differences, and similarities
David Julian McClements
SOFT MATTER (2012)
NMDA Receptor-Dependent Long-Term Potentiation and Long-Term Depression (LTP/LTD)
Christian Luescher et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Presenilins and γ-Secretase: Structure, Function, and Role in Alzheimer Disease
Bart De Strooper et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics
Chie Kojima et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zlokovic
NATURE REVIEWS NEUROSCIENCE (2011)
Crystal structures of the extracellular domain of LRP6 and its complex with DKK1
Zhihong Cheng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?
Alessandro Martorana et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Strategy for effective brain drug delivery
M. Intakhab Alam et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
GSK3: A possible link between beta amyloid peptide and tau protein
Felix Hernandez et al.
EXPERIMENTAL NEUROLOGY (2010)
Choline Acetyltransferase: Celebrating Its Fiftieth Year
Donghai Wu et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Emerging applications of stimuli-responsive polymer materials
Martien A. Cohen Stuart et al.
NATURE MATERIALS (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
An Overview of APP Processing Enzymes and Products
Vivian W. Chow et al.
NEUROMOLECULAR MEDICINE (2010)
Intranasal Delivery-Modification of Drug Metabolism and Brain Disposition
Yin Cheong Wong et al.
PHARMACEUTICAL RESEARCH (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
Influência da doença de Alzheimer na percepção de qualidade de vida do idoso
Keika Inouye et al.
Revista da Escola de Enfermagem da USP (2010)
Dimebon disappointment
Roy W. Jones
ALZHEIMERS RESEARCH & THERAPY (2010)
The Therapeutic Potential of Microencapsulate Implants: Patents and Clinical Trials
Carlos Spuch et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2010)
Brain Drug Delivery System: An Overview
Pushpanjali C. Ligade et al.
CURRENT DRUG THERAPY (2010)
Dendrimers in gene transfection
D. G. Shcharbin et al.
BIOCHEMISTRY-MOSCOW (2009)
Tumour Necrosis Factor Modulation for Treatment of Alzheimer's Disease Rationale and Current Evidence
Edward Tobinick
CNS DRUGS (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses
Efrat Abramov et al.
NATURE NEUROSCIENCE (2009)
GSK-3 is a master regulator of neural progenitor homeostasis
Woo-Yang Kim et al.
NATURE NEUROSCIENCE (2009)
Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis
Tomoko Kuwabara et al.
NATURE NEUROSCIENCE (2009)
GSK3β, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9
I. Dewachter et al.
NEUROBIOLOGY OF DISEASE (2009)
The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: Reversal by guanosine
Andre P. Schmidt et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
Kaushik Ghosal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neurobiology ofAlzheimer′s disease
E Mohandas et al.
Indian Journal of Psychiatry (2009)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
Neil Upton et al.
NEUROTHERAPEUTICS (2008)
New therapeutic targets in the neurovascular pathway in Alzheimer's disease
Berislav V. Zlokovic
NEUROTHERAPEUTICS (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
C. Geoffrey Lau et al.
NATURE REVIEWS NEUROSCIENCE (2007)
The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn
Hyung-Mun Yun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
R. Schliebs et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
The amyloid pathology progresses in a neurotransmitter-specific manner
Karen F. S. Bell et al.
NEUROBIOLOGY OF AGING (2006)
Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level
Amitabha Sengupta et al.
FEBS LETTERS (2006)
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis
C. Wegner et al.
NEUROLOGY (2006)
Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3
Tobias Engel et al.
JOURNAL OF NEUROSCIENCE (2006)
5-HT6 receptors:: a novel target for cognitive enhancement
ES Mitchell et al.
PHARMACOLOGY & THERAPEUTICS (2005)
The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat
CKJ Lieben et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation
T Saito et al.
NATURE MEDICINE (2005)
Proteomic analysis of in vivo phosphorylated synaptic proteins
MO Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons
AR Alvarez et al.
EXPERIMENTAL CELL RESEARCH (2004)
Unfolding the role of protein misfolding in neurodegenerative diseases
C Soto
NATURE REVIEWS NEUROSCIENCE (2003)
Disruption of neurogenesis by amyloid β-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease
NJ Haughey et al.
JOURNAL OF NEUROCHEMISTRY (2002)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
Nonfibrillar diffuse amyloid deposition due to a γ42-secretase site mutation points to an essential role for N-truncated Aβ42 in Alzheimer's disease
S Kumar-Singh et al.
HUMAN MOLECULAR GENETICS (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Clearance of amyloid β-peptide from brain:: transport or metabolism?
BV Zlokovic et al.
NATURE MEDICINE (2000)
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
JR Murrell et al.
ARCHIVES OF NEUROLOGY (2000)
分享论文
